Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials

Journal of Urology

Volumn 185, Issue 1, 2011, Pages 116-120

  Hoffman, Karen E ^a   Nguyen, Paul L ^b   Chen, Ming Hui ^d   Chen, Ronald C ^e   Choueiri, Toni K ^c   Hu, Jim C ^b,c   Kuban, Deborah A ^a   D'Amico, Anthony V ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DEMOGRAPHY; DISEASE FREE SURVIVAL; EDUCATIONAL STATUS; FOLLOW UP; HUMAN; MALE; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SOCIAL STATUS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 78650021945     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.08.086     Document Type: Article

References (30)

1. S.R. Bott, A.A. Freeman, and S. Stenning Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time BJU Int 95 2005 34
2. M.R. Cooperberg, J.M. Broering, and M.S. Litwin The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CapSURE), a national disease registry J Urol 171 2004 1393
3. J.F. Ward, H. Zincke, and E.J. Bergstralh The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy J Urol 172 2004 1328
4. M.S. Anscher, C.N. Robertson, and R. Prosnitz Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update Int J Radiat Oncol Biol Phys 33 1995 37
5. B.C. Leibovich, D.E. Engen, and D.E. Patterson Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin J Urol 163 2000 1178
6. Z. Petrovich, G. Lieskovsky, and J.P. Stein Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer BJU Int 89 2002 604
7. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572
8. I.M. Thompson Jr, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329
9. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924
10. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956
11. C. Zippin, D. Lum, and B.F. Hankey Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute Cancer 76 1995 2343
12. Population Characteristics Surveillence Epidemiology and End Results http://seer.cancer.gov/registries/characteristics.html Accessed June 7, 2009
13. Surveillance, Epidemiology, and End Results (SEER) Program, available at http://www.seer.cancer.gov. SEER (*)Stat Database: Incidence - SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2009 Sub (19732007 varying) - Linked To County Attributes - Total U.S., 19692007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission. Accessed June 8, 2010.
14. N. Krieger, D.R. Williams, and N.E. Moss Measuring social class in US public health research: concepts, methodologies, and guidelines Annu Rev Public Health 18 1997 341
15. M.K. Paasche-Orlow, R.M. Parker, and J.A. Gazmararian The prevalence of limited health literacy J Gen Intern Med 20 2005 175
16. G. Singh, B. Miller, and B. Hankey Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 19751999 NCI Cancer Surveillance Monograph Series, Number 4 2003 National Cancer Institute Bethesda, Maryland NIH Publication No. 03-0000
17. N.G. Coburn, U. Guller, and N.N. Baxter Adjuvant therapy for resected gastric cancerrapid, yet incomplete adoption following results of intergroup 0116 trial Int J Radiat Oncol Biol Phys 70 2008 1073
18. R.S. Punglia, J.C. Weeks, and B.A. Neville Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information J Clin Oncol 24 2006 3474
19. I.M. Thompson, C.M. Tangen, and E.A. Klein Is there a standard of care for pathologic stage T3 prostate cancer? J Clin Oncol 27 2009 2898
20. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760
21. J.I. Epstein, A.W. Partin, and J. Sauvageot Prediction of progression following radical prostatectomy A multivariate analysis of 721 men with long-term follow-up Am J Surg Pathol 20 1996 286
22. C. Parker, M.R. Sydes, and C. Catton Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy BJU Int 99 2007 1376
23. Radiotherapy - Adjuvant Versus Early Salvage (RAVES) NCT00860652 http://www.clinicaltrials.gov
24. K.R. Ghani, K. Grigor, and D.N. Tulloch Trends in reporting Gleason score 1991 to 2001: changes in the pathologist's practice Eur Urol 47 2005 196
25. E.B. Smith, H.F. Frierson Jr, and S.E. Mills Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? Cancer 94 2002 2282
26. T.H. Van der Kwast, M. Bolla, and H. Van Poppel Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178
27. C.M. Moinpour, K.A. Hayden, and J.M. Unger Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy J Clin Oncol 26 2008 112
28. J.L. Malin, K.L. Kahn, and J. Adams Validity of cancer registry data for measuring the quality of breast cancer care J Natl Cancer Inst 94 2002 835
29. J.B. Yu, C.P. Gross, and L.D. Wilson NCI SEER public-use data: applications and limitations in oncology research Oncology (Williston Park) 23 2009 288
30. G.L. Lu-Yao, A.L. Potosky, and P.C. Albertsen Follow-up prostate cancer treatments after radical prostatectomy: a population-based study J Natl Cancer Inst 88 1996 166